US Stock MarketDetailed Quotes

NVEE NV5 Global

Watchlist
  • 19.140
  • +0.640+3.46%
Close Jan 8 16:00 ET
  • 19.125
  • -0.015-0.08%
Post 17:08 ET
1.25BMarket Cap35.44P/E (TTM)

NV5 Global Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

NV5 Global Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 230.500M--
--2024/Q4-- / 243.819M--
Nov 7, 20242024/Q3250.885M / 251.372M--
Aug 7, 20242024/Q2236.326M / 234.959M--
May 8, 20242024/Q1213.295M / 209.183M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 230.500M--
--2024/Q4-- / 243.819M--
Nov 7, 20242024/Q3250.885M / 251.372M--
Aug 7, 20242024/Q2236.326M / 234.959M--
May 8, 20242024/Q1213.295M / 209.183M--

Unlock Free Earnings Estimates

NV5 Global Earnings Reports

  • NV5 Global | 10-Q: Q3 2024 Earnings Report

    Nov 12, 2024 12:57 ET

  • NV5 Global | 8-K: NV5 ANNOUNCES PRELIMINARY UNAUDITED RECORD THIRD QUARTER RESULTS

    Nov 7, 2024 16:32 ET

  • NV5 Global | 10-Q: Q2 2024 Earnings Report

    Aug 8, 2024 13:49 ET

  • NV5 Global | 8-K: NV5 ANNOUNCES SECOND QUARTER RESULTS AND RAISES GUIDANCE

    Aug 7, 2024 16:23 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Collegium Pharmaceutical
    COLL
    +14.41%
    eBay
    EBAY
    +9.86%
    Halozyme Therapeutics
    HALO
    +5.02%
    SilverCrest Metals
    SILV
    +4.63%
    Workday
    WDAY
    +2.01%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Jan 9, 2025

    Strong Buy

    • Buy

      75.00%

    • Hold

      25.00%

    • Sell

      0.00%

    Price Target

    No Data